chr19-10514187-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_030760.5(S1PR5):c.825G>A(p.Val275=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00324 in 1,612,358 control chromosomes in the GnomAD database, including 162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 78 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 84 hom. )
Consequence
S1PR5
NM_030760.5 synonymous
NM_030760.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.260
Genes affected
S1PR5 (HGNC:14299): (sphingosine-1-phosphate receptor 5) The lysosphingolipid sphingosine 1-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Its actions may be both intracellular as a second messenger and extracellular as a receptor ligand. S1P and the structurally related lysolipid mediator lysophosphatidic acid (LPA) signal cells through a set of G protein-coupled receptors known as EDG receptors. Some EDG receptors (e.g., EDG1; MIM 601974) are S1P receptors; others (e.g., EDG2; MIM 602282) are LPA receptors.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 19-10514187-C-T is Benign according to our data. Variant chr19-10514187-C-T is described in ClinVar as [Benign]. Clinvar id is 781454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.26 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
S1PR5 | NM_030760.5 | c.825G>A | p.Val275= | synonymous_variant | 2/2 | ENST00000333430.6 | |
S1PR5 | NM_001166215.2 | c.825G>A | p.Val275= | synonymous_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
S1PR5 | ENST00000333430.6 | c.825G>A | p.Val275= | synonymous_variant | 2/2 | 1 | NM_030760.5 | P1 | |
S1PR5 | ENST00000439028.3 | c.825G>A | p.Val275= | synonymous_variant | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0176 AC: 2672AN: 152214Hom.: 78 Cov.: 33
GnomAD3 genomes
AF:
AC:
2672
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00430 AC: 1050AN: 244384Hom.: 34 AF XY: 0.00329 AC XY: 439AN XY: 133342
GnomAD3 exomes
AF:
AC:
1050
AN:
244384
Hom.:
AF XY:
AC XY:
439
AN XY:
133342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00174 AC: 2544AN: 1460026Hom.: 84 Cov.: 30 AF XY: 0.00151 AC XY: 1100AN XY: 726384
GnomAD4 exome
AF:
AC:
2544
AN:
1460026
Hom.:
Cov.:
30
AF XY:
AC XY:
1100
AN XY:
726384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0176 AC: 2680AN: 152332Hom.: 78 Cov.: 33 AF XY: 0.0174 AC XY: 1299AN XY: 74504
GnomAD4 genome
AF:
AC:
2680
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
1299
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at